Sheng-Lan Tan (Shenglan Tan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Venous Thromboembolism

Randomized Controlled Trial

Respiratory Syndrome Coronavirus

Top Venues

Journal of thrombosis and thrombolysis

BMC health services research

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Hua Liu, Yang-Zhao Zhou, Tian-Yu Li, Da-Bin Kuang, Qun Liang, Lei Chen, Da-Feng Yang, Xia Zhang, Sheng-Lan Tan
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment. Journal of thrombosis and thrombolysis (2024)
Zhousheng Yang, Tianyu Li, Chunyan Wang, Mingyu Meng, Sheng-Lan Tan, Lei Chen
Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF- κ B Signaling Pathway. Mediators of inflammation 2023 (2023)
Lei Chen, Yang-Zhao Zhou, Xin-Min Zhou, Li-Ming Liu, Ping Xu, Xia Zhang, Sheng-Lan Tan
Evaluation of the "safe multidisciplinary app-assisted remote patient-self-testing (SMART) model" for warfarin home management during the COVID-19 pandemic: study protocol of a multi-center randomized controlled trial. BMC health services research 21 (1) (2021)